Total Payments
$1,734
2024 Payments
$20.32
Companies
17
Transactions
114
Medicare Patients
3,552
Medicare Billing
$292,944
Payment Breakdown by Category
Food & Beverage$1,734 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,734 | 114 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $433.57 | 40 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $387.91 | 25 | $0 (2020) |
| NxStage Medical, Inc. | $196.24 | 4 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $144.12 | 11 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $106.18 | 6 | $0 (2019) |
| Allergan Inc. | $100.73 | 5 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $76.88 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $74.63 | 5 | $0 (2020) |
| Purdue Pharma L.P. | $40.76 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $29.76 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.32 | 1 | Alexion Pharmaceuticals, Inc. ($20.32) |
| 2021 | $196.24 | 4 | NxStage Medical, Inc. ($196.24) |
| 2020 | $124.01 | 8 | PFIZER INC. ($46.57) |
| 2019 | $445.53 | 29 | PFIZER INC. ($125.66) |
| 2018 | $413.17 | 29 | AstraZeneca Pharmaceuticals LP ($128.83) |
| 2017 | $534.56 | 43 | PFIZER INC. ($142.59) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/12/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Rare Disease | ||||||
| 11/19/2021 | NxStage Medical, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $42.86 | General |
| Category: Nephrology | ||||||
| 11/19/2021 | NxStage Medical, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Nephrology | ||||||
| 11/19/2021 | NxStage Medical, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Nephrology | ||||||
| 04/07/2021 | NxStage Medical, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $110.77 | General |
| Category: Nephrology | ||||||
| 02/25/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Neuroscience | ||||||
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/04/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/03/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/28/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: VACCINES | ||||||
| 01/21/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/14/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: VACCINES | ||||||
| 01/07/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Neuroscience | ||||||
| 12/03/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.75 | General |
| 10/29/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/14/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: VACCINES | ||||||
| 10/08/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), VAQTA, GARDASIL9 | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: VACCINE | ||||||
| 09/10/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: GASTROINTESTINAL | ||||||
| 08/27/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/19/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: VACCINES | ||||||
| 08/13/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 779 | 1,061 | $172,055 | $78,622 |
| 2022 | 12 | 839 | 1,130 | $168,025 | $78,360 |
| 2021 | 14 | 933 | 1,276 | $175,182 | $72,285 |
| 2020 | 17 | 1,001 | 1,457 | $159,277 | $63,677 |
Total Patients
3,552
Total Services
4,924
Medicare Billing
$292,944
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 331 | $70,440 | $27,328 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 228 | 367 | $51,428 | $22,437 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 156 | 156 | $33,709 | $20,791 | 61.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 42 | 42 | $5,771 | $3,290 | 57.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $3,485 | $1,562 | 44.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $1,899 | $1,435 | 75.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 63 | 68 | $3,895 | $668.38 | 17.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $652.68 | $639.66 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $612.50 | $388.31 | 63.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 24 | $162.66 | $81.84 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 237 | 409 | $88,822 | $35,635 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 204 | 315 | $34,892 | $18,447 | 52.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 98 | 98 | $21,743 | $13,496 | 62.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 38 | $3,444 | $2,605 | 75.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 27 | 27 | $3,930 | $1,948 | 49.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $2,316 | $1,592 | 68.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 40 | $1,243 | $1,218 | 98.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,143 | $919.53 | 42.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 89 | 96 | $7,273 | $911.10 | 12.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 44 | 44 | $1,375 | $889.16 | 64.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $683.76 | $647.72 | 94.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 15 | $161.85 | $51.55 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 228 | 422 | $82,299 | $25,988 | 31.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 233 | 378 | $41,862 | $17,079 | 40.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 88 | 88 | $17,867 | $12,336 | 69.0% |
About Dr. Kenneth Kepler, M.D
Dr. Kenneth Kepler, M.D is a Internal Medicine healthcare provider based in Kihei, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649360033.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Kepler, M.D has received a total of $1,734 in payments from pharmaceutical and medical device companies, with $20.32 received in 2024. These payments were reported across 114 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,734).
As a Medicare-enrolled provider, Kepler has provided services to 3,552 Medicare beneficiaries, totaling 4,924 services with total Medicare billing of $292,944. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Kihei, HI
- Active Since 10/13/2006
- Last Updated 04/23/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649360033
Products in Payments
- FARXIGA (Drug) $211.27
- CHANTIX (Drug) $201.59
- NXSTAGE SYSTEM ONE (Device) $196.24
- SYMBICORT (Drug) $80.81
- TOUJEO (Drug) $77.77
- PREVNAR - 13 (Biological) $65.70
- QVAR (Drug) $63.10
- BYDUREON (Drug) $56.32
- VIAGRA (Drug) $54.97
- ASMANEX (Drug) $53.15
- LYRICA (Drug) $53.11
- JANUVIA (Drug) $50.29
- VRAYLAR (Drug) $40.94
- BEVESPI AEROSPHERE (Drug) $39.51
- LINZESS (Drug) $37.50
- INVOKANA (Drug) $29.76
- Aimovig (Biological) $29.49
- SOLIQUA (Drug) $28.41
- COLOGUARD (Device) $27.77
- ROTATEQ (Biological) $27.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.